Vascular Solutions, Inc. (VASC) Tops Q3 EPS by 1c; Guides In-Line

Go back to Vascular Solutions, Inc. (VASC) Tops Q3 EPS by 1c; Guides In-Line

Analysts Expect More Margin Expansion and Top Line Growth at Vascular (VASC)

October 19, 2012 12:41 PM EDT

Canaccord Genuity reiterated a Buy on Vascular Solutions (NASDAQ: VASC) and raised its price target to $18.75 (from $18.00).

Analyst Jason R. Mills said "We expect VASC to continue to add new products through both internal development and M&A, with which we... More